SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Chemicals aims to enter out-licensing arrangements with MNCs

20 Sep 2012 Evaluate

Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals (Orchid Pharma), which is engaged in drug discovery in therapeutic segments, is planning to enter into out-licensing arrangements with multinational pharma companies (MNCs), after the successful completion of trials.

The company is in the process of transitioning its new chemical entities through various stages of pre-clinical and human clinical studies. These segments include diabetes, inflammation, cancer, auto immune disorders, anti infectives and obesity.

Orchid Pharma Share Price

570.50 6.40 (1.13%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×